Cervical Neoplasia Clinical Trial
Official title:
Evaluating Thermal Ablation in the Treatment of Cervical Neoplasia
Longitudinal study in Burundi to evaluate the effectiveness, the acceptability and safety of thermal ablation in the treatment of cervical neoplasia.
The study population consisted of women with an abnormal VIA test or an abnormal colposcopy examination. A total of 86 women with lesions eligible to ablative treatment were counselled and treated by thermal ablation. Informed consent was signed by each participant. Just after treatment, they were inquired about the level of pain during the procedure, and their level of satisfaction with the treatment. They were followed-up at 6 weeks for any complication and re-assessed by VIA and colposcopy at 12 months for any persistent or recurrent lesion and for any adverse event. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00702208 -
Feasibility of Delphi Screener for Cervical Cytology
|
Phase 2 | |
| Completed |
NCT02253719 -
Cervical Cancer Screening in HIV Positive and Negative Women in Cambodia
|
N/A | |
| Not yet recruiting |
NCT02908607 -
Thermal Imaging for Evaluation of the Cervix
|
Phase 1/Phase 2 | |
| Withdrawn |
NCT00503919 -
Measurement of Digital Colposcopy for Fluorescence Spectroscopy of TNC Using a Second Device
|
Phase 1 | |
| Terminated |
NCT00342173 -
Costa Rican Natural History Study of HPV and Cervical Neoplasia
|
||
| Completed |
NCT00435214 -
Human Papillomavirus (HPV) and Risk of Cervical Precancer and Cancer
|
||
| Completed |
NCT01086709 -
Crossover Vaccination of Women Previously Randomized Into Protocol 04-C-N191
|
||
| Completed |
NCT00766701 -
Spectroscopic Evaluation of Cervical Neoplasia
|
N/A | |
| Completed |
NCT00456807 -
Complementary Testing to Evaluate Immunogenicity of Human Papillomavirus (HPV) Vaccine (580299) in Healthy Female Subjects Aged >/= 26 Years
|
Phase 3 |